Influence of some detoxification enzyme polymorphisms on cytogenetic biomarkers between individuals exposed to very low doses of 1,3-butadiene

Journal of Occupational and Environmental Medicine

Volumn 51, Issue 7, 2009, Pages 811-821

  Bukvic, Nenad ^a,b,c   Lovreglio, Piero ^a   Fanelli, Margherita ^a   Susca, Francesco C ^a   Ballini, Andrea ^a   Lastella, Patrizia ^a   Foà, Vito ^d   Fustinoni, Silvia ^d   Soleo, Leonardo ^a   Guanti, Ginevra ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c University Hospital   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; BIOLOGICAL MARKER; COPOLYMER; CYTOCHROME P450 2E1; EPOXIDE HYDROLASE; GENOMIC DNA; GLUTATHIONE TRANSFERASE; MICROSOME ENZYME; PLASTIC; RUBBER; STYRENE;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DETOXIFICATION; ENZYME ACTIVITY; ENZYME POLYMORPHISM; GENETIC POLYMORPHISM; GENOTOXICITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INDUSTRIAL WORKER; LYMPHOCYTE; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PETROCHEMICAL INDUSTRY; PLASTIC INDUSTRY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SISTER CHROMATID EXCHANGE; SMOKING HABIT;

ADULT; BIOLOGICAL MARKERS; BUTADIENES; CYTOGENETIC ANALYSIS; HUMANS; MALE; METABOLIC DETOXICATION, DRUG; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTAGENS; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SISTER CHROMATID EXCHANGE; YOUNG ADULT;

EID: 68749087532     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3181a88d7f     Document Type: Article

References (68)

1. Albertini RJ, Anderson D, Douglas GR, et al. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat Res. 2000;463:111-172. (Pubitemid 30460066)
2. Norppa H. Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett. 2004;149:309-334.
3. Norppa H. Cytogenetic biomarkers. In: Mechanistic Considerations in the Molecular Epidemiology of Cancer. IARC Science Publication, Vol.157. Lyon, France: IARC. 2004:179-205.
4. Hagmar L, Brogger A, Hansteen IL, et al. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: nordic study group on the health risk of chromosome damage. Cancer Res. 1994;54:2919-2922. (Pubitemid 24187773)
5. Bonassi S, Hagmar L, Strömberg U, et al. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res. 2000;60:1619-1625.
6. Norppa H. Cytogenetic markers of susceptibility: influence of polymorphic carcinogen- metabolizing enzymes. Environ Health Perspect. 1997;105(Suppl 4):829-835. (Pubitemid 27372969)
7. Norppa H. Influence of genetic enzyme polymorphisms on cytogenetic biomarkers. In: Anderson D, Karakaya AE, Sram RJ, eds. Human Monitoring After Environmental and Occupational Exposure to Chemical and Physical Agents. NATO Science Series A: Life Sciences, Vol.313. Amsterdam: IOS Press; 2000;300-311.
8. Norppa H. Genetic polymorphisms and chromosome damage. Int J Hyg Enviro Health. 2001;204:31-38.
9. Norppa H. Genetic susceptibility, biomarker responses and cancer. Mutat Res. 2003;544:339-348. (Pubitemid 37487676)
10. Willett WC. Diet, nutrition and avoidable cancer. Environ Health Perspect. 1995;103(Suppl 8):165-170.
11. Georgiadis P, Demopoulos NA, Topinka J, et al. Impact of phase I and II enzyme polymorphisms on lymphocyte DNA adducts in subjects exposed to urban air pollution and environmental tobacco smoke. Toxicol Lett. 2004;149:269-280. (Pubitemid 38469845)
12. IARC. Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide: 1,3-Butadiene. Vol.71. Lyon, France: IARC; 1999:109-225.
13. American Conference of Governmental Industrial Hygienists. Threshold Limit Values and Biological Exposure Indices. Cincinnati, OH: American Conference of Governmental Industrial Hygienists; 2003.
14. IARC. Occupational Exposures to Mists and Vapours From Strong Inorganic Acids and Other Industrial Chemicals: 1,3- Butadiene. Vol.54. Lyon, France: IARC; 1992:110-300.
15. Brunnemann KD, Kagan MR, Cox JE, Hoffmann D. Analysis of 1,3 butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection. Carcinogenesis. 1990;11:1863-1868. (Pubitemid 20331457)
16. NTP - National Toxicology Program. Toxicology and Carcinogenesis Studies of 1,3-Butadiene (CAS No. 106-99-0) in B6C3F1 Mice (Inhalation Studies). Vol.288. Research Triangle Park, NC: NTP TR. 1993:1-111.
17. Owen PE, Glaister JR, Gaunt IF, Pullinger DH. Inhalation toxicity studies with 1,3- butadiene. III. Two year toxicity/carcinogenicity study in rats. Am Ind Hyg Assoc J. 1987;48:407-413.
18. Tuimala J, Szekely G, Gundy S, Hirvonen A, Norppa H. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis. 2002;23:1003-1008. (Pubitemid 34752956)
19. Wormhoudt LW, Commandeur JN, Vermeulen NP. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Crit Rev Toxicol. 1999;29:59-124.
20. Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001;10:1239-1248. (Pubitemid 34027754)
21. Norppa H, Hirvonen A, Järventaus H, et al. Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane cultured human lymphocytes. Carcinogenesis. 1995;16:1261-1264.
22. Vlachodimitropoulos D, Norppa H, Autio K, et al. GSTT1-dependent induction of centromere-negative and-positive micronuclei by 1,2:3,4-diepoxybutane in cultured human lymphocytes. Mutagenesis. 1997;12:397-403. (Pubitemid 27417581)
23. Landi S, Norrpa H, Frenzilli G, et al. Individual sensitivity to cytogenic effects of 1,2:3,4-diepoxybutane in cultured human lymphocytes: influence of glutathione S-transferase M1, P1 and T1 genotypes. Pharmacogenetics. 1998;8:461-471. (Pubitemid 29043378)
24. Schlade-Bartusiak K, Sasiadek M, Kozlowska J. The influence of GSTM1 and GSTT1 genotypes on the induction of sister chromatid exchanges and chromosome aberrations by 1,2:3,4-diepoxybutane. Mutat Res. 2000;465:69-75. (Pubitemid 30119920)
25. Uusküla M, Järventaus H, Hirvonen A, Sorsa M, Norppa H. Influence of GSTM1 genotype on sister chomatid exchange induction by styrene-7,8-oxide and epoxy- 3-butene in cultured human lymphocytes. Carcinogenesis. 1995;16:947-950.
26. Bernardini S, Hirvonen A, Pelin K, Norppa H. Induction of sister chromatid exchange by 1,2-epoxy-3-butene in cultured human lymphocytes: influence of GSTT1 genotype. Carcinogenesis. 1998;19:377-380. (Pubitemid 28375437)
27. Sasiadek M, Hirvonen A, Noga L, Paprocka-Borowicz M, Norppa H. Glutathione S-transferase M1 genotype influences sister chromatid exchange induction but not adaptive response in human lymphocytes treated with 1,2-epoxy-3-butene. Mutat Res. 1999;439:207-212. (Pubitemid 29094812)
28. Sorsa M, Osterman-Golkar S, Peltonen K, Saarikoski ST, Sram R. Assessment of exposure to butadiene in the process industry. Toxicology. 1996;113:77-83. (Pubitemid 26364077)
29. Sorsa M, Peltonen K, Anderson D, Demopoulos NA, Neumann HG, Osterman- Golkar S. Assessment of environmental and occupational exposures to butadiene as a model for risk estimation of petrochemical emissions. Mutagenesis. 1996;11:9-17. (Pubitemid 26041089)
30. Srám RJ, Rössner P, Peltonen K, et al. Chromosomal aberrations, sister-chromatid exchanges, cells with high frequency of SCE, micronuclei and comet assay paramenters in 1,3-butadiene-exposed workers. Mutat Res. 1998;419:145-154. (Pubitemid 28512980)
31. Hayes RB, Zhang L, Yin S, et al. Genotoxic markers among butadiene polymer workers in China. Carcinogenesis. 2000;21:55-62. (Pubitemid 30064144)
32. Zhao C, Vodicka P, Sram RJ, Hemminki K. DNA adducts of 1,3-butadiene in humans: relationships to exposure, GST genotypes, single-strand breaks, and cytogenetic end points. Environ Mol Mutagen. 2001;37:226-230. (Pubitemid 32411128)
33. Begmann P, Srám RJ, Neumann HG. Hemoglobin adducts of epoxybutene in workers occupationally exposed to 1,3- butadiene. Arch Toxicol. 2001;74:680-687. (Pubitemid 32208894)
34. Albertini RJ, Sram RJ, Vacek PM, et al. Biomarkers for assessing occupational exposure to 1,3-butadiene. Chem Biol Interact. 2001;135/136:429- 453.
35. Abdel-Rahman SZ, Ammenheuser MM, Ward JB Jr. Human sensitivity to 1,3- butadiene: role of microsomal epoxide hydrolase polymorphisms. Carcinogenesis. 2001;22:415-423.
36. Fustinoni S, Soleo L, Warholm M, et al. Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans. Cancer Epidemiol Biomarkers Prev. 2002;11:1082-1090. (Pubitemid 35192661)
37. ISCN. An International System for Human Cytogenetic Nomenclature, Birth Defects: Original Article Series. Vol.IXV, No.8. New York: The National Foundation; 1978:125-255.
38. Bukvic N, Gentile M, Susca F, et al. Sex chromosome loss, micronuclei, sister chromatid exchange and aging: a study including 16 centenarians. Mutat Res. 2001;498:159-167. (Pubitemid 32973671)
39. Carrano AV, Moore DH. The rational methodology for quantifying sister chromatid exchange in humans. In: Hendle JA, ed. New Horizons in Genetic Toxicology. New York: Academic Press; 1982:267-307.
40. Hassett C, Lin J, Carty CL, Laurenzana EM, Omiecinski CJ. Hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. Arch Biochem Biophys. 1997;337:275-283. (Pubitemid 27198192)
41. Schlade-Bartusiak K, Rozik K, Laczmanska I, Ramsey D, Sasiadek M. Influence of GSTT1, mEH, CYP2E1 and RAD51 polymorphisms on diepoxybutane-induced SCE frequency in cultured human lymphocytes. Mutat Res. 2004;558:121-130. (Pubitemid 38229640)
42. Baxter SW, Choong DY, Campbell IG. Microsomal epoxide hydrolase polymorphism and susceptibility to ovariana cancer. Cancer Lett. 2002;177:75-81. (Pubitemid 34102401)
43. Brockmöller J, Gross D, Kreb R, Drakoulis N, Roots I. Correlation between trans-stilbene oxide-gluthatione conjugation activity and the deletion mutation in the gluthatione S-transferase class mu gene detected by polymerase chain reaction. Biochem Pharmacol. 1992;43:647-650.
44. Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994;300:271-276. (Pubitemid 24151046)
45. Warholm M, Rane A, Alexandrie AK, Monaghan G, Rannung A. Genotypic and phenotypic determination of polymorphic glutathione transferase T1 in a Swedish population. Pharmacogenetics. 1995;5:252-254.
46. Ahlberg RW, Sorsa M, Pfafli P, Maki- Paakanen J, Viinanen R. Genotoxicity and Exposure Assessment in the Manufacture of 1,3-Butadiene. WHO Report on Occupational Health in the Chemical Industry. Copenhagen: WHO; 1992:199-204.
47. Sorsa M, Autio K, Demopoulos NA, et al. Human cytogenetic biomonitoring of occupational exposure to 1,3-butadiene. Mutat Res. 1994;309:321-326. (Pubitemid 24268445)
48. Hayes RB, Xi L, Bechtold WE, et al. Hprt mutation frequency among workers exposed to 1,3-butadiene in China. Toxicology. 1996;113:100-105. (Pubitemid 26364080)
49. Xi L, Zhang L, Wang Y, Smith MT. Induction of chromosome-specific aneuploidy and micronuclei in human lymphocytes by metabolites of 1,3-butadiene. Carcinogenesis. 1997;18:1687-1693. (Pubitemid 28134672)
50. Ruhe RL, Jannerfeldt ER. Health Hazard Evaluation Determination, Metamora Products Corporation, Elkland, PA (Report No. HE-80-188-797). Cincinnati, OH: National Institute for Occupational Safety and Health; 1980.
51. Ammenheuser MM, Bechtold WE, Abdel- Rahman SZ, Rosenblatt JI, Hastings- Smith DA, Ward JB Jr. Assessment of 1,3-butadiene exposure in polymer production workers using hprt mutations in lymphocytes as a biomarker. Environ Health Perspect. 2001;109:1249-1255. (Pubitemid 34055913)
52. Fustinoni S, Perbellini L, Soleo L, Manno M, Foà V. Biological monitoring in occupational exposure to low levels of 1,3-butadiene. Toxicol Lett. 2004;149:353-360. (Pubitemid 38469853)
53. Sarto F, Faccioli MC, Cominato I, Levis AG. Aging and smoking increase the frequency of sister chromatid exchange (SCE) in man. Mutat Res. 1985;144:183-187. (Pubitemid 16217547)
54. Hirsch BA, Sentz KK, McGue M. Genetic and environmental influences on baseline SCE. Environ Mol Mutagen. 1992;20:2-11.
55. Lazutka JR, Dedonyte V, Krapavickaite D. Sister chromatid exchanges and their distribution in human lymphocytes in relation to age, sex and smoking. Mutat Res. 1994;306:173-180. (Pubitemid 24110376)
56. Barale R, Chelotti L, Davini T, et al. Sister chromatid exchange and micronucleus frequency in human lymphocytes of 1650 subjects in an Italian population: II. Contribution of sex, age and lifestyle. Environ Mol Mutagen. 1998;31:228-242. (Pubitemid 28221594)
57. Bukvic N, Bavaro P, Elia G, Cassano F, Fanelli M, Guanti G. Sister chromatid exchange (SCE) and micronucleus (MN) frequencies in lymphocytes of gasoline station attendants. Mutat Res. 1998;415:25-33. (Pubitemid 28378525)
58. Das BC, Rani R, Mitra AB, Luthra UK. Baseline frequency of sister-chromatid exchanges (SCE) in newborn lymphocytes and its relationship to in vivo aging in humans. Mutat Res. 1985;144:85-88. (Pubitemid 15228411)
59. Lovreglio P, Bukvic N, Fustinoni S, et al. Lack of genotoxic effect in workers exposed to very low doses of 1,3-butadiene. Arch Toxicol. 2006;80:378-381. (Pubitemid 43725222)
60. Weber WW. Influence of heredity on human sensitivity to environmental chemicals. Environ Mol Mutagen.1995;25:102-114.
61. Benhamou S, Reinikainen M, Bouchardy C, Dayer P, Hirvonen A. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res. 1998;58:5291-5293. (Pubitemid 28551101)
62. Cajas-Salazar N, Au WW, Zwischenberger JB, et al. Effect of epoxide hydrolase polymorphisms on chromosome aberrations and risk for lung cancer. Cancer Genet Cytogenet. 2003;145:97-102. (Pubitemid 36993738)
63. Lancaster JM, Browniee HA, Bell DA, et al. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog. 1996;17:160-162.
64. Jourenkova-Mironova N, Mitrunen K, Bouchardy C, Dayer P, Benhamou S, Hirvonen A. High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx and larynx cancer. Cancer Res. 2000;60:534-536. (Pubitemid 30094545)
65. Casson AG, Zheng Z, Chiasson D, et al. Associations between genetic polymorphisms of phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev. 2003;27:139-146. (Pubitemid 36429594)
66. Huang WY, Chatterjee N, Chanock S, et al. Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2005;14:152-157. (Pubitemid 40165296)
67. Abdel-Rahman SZ, Ammenheuser MM, Omiecinski CJ, Wickliffe JK, Rosenblatt JI, Ward JB Jr. Variability in human sensitivity to 1,3-butadiene: Influence of polymorphisms in the 5′-flank region of the microsomal epoxide hydrolase gene (EPHX1). Toxicol Sci. 2005;85:624-631.
68. Vodicka P, Kumar R, Stetina R, et al. Markers of individual susceptibility and DNA repair rate in workers exposed to xenobiotics in a tire plant. Environ Mol Mutagen. 2004;44:283-292. (Pubitemid 39447232)